Tirzepatide for diabetes mellitus

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Also followed for narrower conditions: Diabetes Mellitus, Type 2, Prediabetic State

Why this status

  1. 25 Jun 2026: Trial started, NCT07707778
  2. 16 Jul 2026: Trial registered, NCT07707778

The trials

NCT07707778: Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV

State
Under way
Phase
Phase 4
People
60 planned
Started
25 Jun 2026
Primary completion
Dec 2027
Arms
Interventional
Results
None posted
  1. 25 Jun 2026: Trial started
  2. 16 Jul 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Arm 5- Tirzepatide, Mounjaro, Tirzepatide (LIPOLESS de Laboratorio de Productos Eticos C.E.I.S.A.), Zepbound.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.